Literature DB >> 2826340

TPA induction of Epstein-Barr virus early antigens in Raji cells is blocked by selective protein kinase-C inhibitors.

J Lazdins1, C Zompetta, S Grimaldi, G Barile, M Venanzoni, L Frati, A Faggioni.   

Abstract

We have shown that modulation of intracellular calcium in EBV latently infected cells could induce the expression of viral antigens, and suggested that a protein kinase-C (PKC) may play a major role in the EBV genome activation. We now report further investigations on the role of PKC using 2 selective enzymatic inhibitors [1-(5-Isoquinolinylsulfonyl)-2-methylpiperazine] (H-7) and Staurosporine. We show that these inhibitors can abrogate the inductive effect of TPA or the combination of TPA plus n-butyrate. The inhibitors have no effect on induction by calcium ionophores or by viral superinfection. In this context the effect of verapamil (a specific calcium channel blocker) and of several calmodulin antagonists was investigated. No inhibitory effect of these agents could be demonstrated on any of the induction systems examined. These observations strengthen the idea that in some instances cellular PKC plays a role in the expression of viral antigens; however, alternative regulatory mechanisms cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826340     DOI: 10.1002/ijc.2910400624

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.

Authors:  E M Fuentes-Pananá; R Peng; G Brewer; J Tan; P D Ling
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication.

Authors:  Marisa Granato; Roberta Santarelli; Antonella Farina; Roberta Gonnella; Lavinia Vittoria Lotti; Alberto Faggioni; Mara Cirone
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

3.  Differential effect of TPA on cell growth and Epstein-Barr virus reactivation in epithelial cell lines derived from gastric tissues and B cell line Raji.

Authors:  M Kanamori; M Tajima; Y Satoh; Y Hoshikawa; Y Miyazawa; K Okinaga; T Kurata; T Sairenji
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

4.  Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus.

Authors:  R Goswami; S Gershburg; A Satorius; E Gershburg
Journal:  Antiviral Res       Date:  2012-10-08       Impact factor: 5.970

5.  Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6.

Authors:  L Flamand; J Menezes
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Epstein-Barr virus latent messages with shuffled leader exons: remnants of circumgenomic transcription?

Authors:  L Qu; D T Rowe
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.

Authors:  C L Miller; J H Lee; E Kieff; R Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C.

Authors:  A H Davies; R J Grand; F J Evans; A B Rickinson
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.